China’s top court affirms German drugmaker Bayer’s win in Xarelto patent suit
China’s Supreme People’s Court upheld two lower court rulings in favor of the Nanjing Intellectual Property Administration of Jiangsu province in two separate complaints lodged by Chinese generic manufacturer Nanjing Hencer Pharmaceutical Co., Ltd. (南京恒生制药有限公司) and its wholly-owned subsidiary Nanjin